Filming New Multi Million Pound Facility

/in /by

Filming in the state of the art control room

We’ve just completed filming the amazing new NBIF (National Buried Infrastructure Facility) at University of Birmingham, which is unique in the world and led to a very cool Linked In posting by Nikolaos Venetsaneas, who is Business Engagement Manager at the University.

Just click on the logo below to see the post:

Here’s what they said about us:

World leading facility

Yesterday, we had the pleasure of recording a video with Good Call Media at the National Buried Infrastructure Facility (#NBIF_UK) to showcase the cutting-edge MTS Systems Corporation equipment and capabilities available within the facility.
(We even had the opportunity to unbox ‘Big Bertha’ : our
largest 200-tonne actuator!).🙂

The aim is to share our expertise, advanced technologies, and groundbreaking solutions globally with industry stakeholders and markets, giving NBIF unparalleled international reach and visibility.

Fiona filming on the moving floor

A big thanks to:
*Good Call Media team (Fiona Molloy, Nik Wood)
*MTS Systems Corporation team (Paul Hold, Paul Lehman, Garth Su PhD MBA)
* #NBIF_UK team (Nicole Metje, Asaad Faramarzi, Kieran Hansard, Christopher Harbutt, Ethan Ashton, Scott Hockell)

 

 

We say – “a big thanks Nik”.

 

On Wall Street

/in /by

 

We hosted Volition RX’s Capital Markets Day in the New York Stock Exchange.

Nik Wood hosted the video and the live event inside the Stock Exchange and Good Call Media co-owner, Fiona Molloy, was on camera for the session (which included a trip to the busy stock exchange trading floor) and also edited videos that were used in the presentations.

Volition is a multi-national epigenetics company powered by Nu.Q®, its proprietary nucleosome quantification platform. Through its subsidiaries, Volition is developing simple, easy to https://youtu.be/QBvzhwCzc4Euse, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients

but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.

Volition’s research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.

Volition is a multi-national epigenetics company powered by Nu.Q®, its proprietary nucleosome quantification platform. Through its subsidiaries, Volition is developing simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.

Volition’s research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.